| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/09/2004 | EP1171441B1 Morphinoid compounds |
| 06/09/2004 | EP1007504B1 Sterilized 5-aminolevulinic acid |
| 06/09/2004 | CN1503680A Ascorbic a cid analogs for metalloradiopharmaceuticals |
| 06/09/2004 | CN1502322A Pharmaceutical dosage form and method of making |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6746661 Biocompatible component, therapeutically active component comprising a non-radioactive drug, and a radiopaque marker; seed has a size and shape suitable for passing through the bore of a 10 gauge needle |
| 06/08/2004 | CA2100256C A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion,and the use of said agents for said purpose |
| 06/03/2004 | WO2004045651A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils |
| 06/03/2004 | WO2004045649A1 Contrast medium for representing lymph nodes |
| 06/03/2004 | WO2004029093A3 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106548 amide cyclization; for altering stability and specificity of receptor-targeted agents |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/02/2004 | EP1424343A1 Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/02/2004 | EP1424083A1 Diagnostic agent for pancreatic exocrine function |
| 06/02/2004 | EP1423526A2 An enzymatic process for the synthesis of organo-fluorine compounds |
| 06/02/2004 | EP1423152A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1162626B1 Radioactive microsphere and method for preparation thereof |
| 06/02/2004 | EP0769966B1 Biotin compounds for targetting tumors and sites of infection |
| 06/01/2004 | US6743925 Nitroimidazole derivative and diagnostic imaging agent containing the same |
| 06/01/2004 | US6743792 Antiinflammatory agents |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | US6743411 Extracorporal system for treating disease with radionucleotides |
| 05/27/2004 | WO2004044227A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | WO2004043498A1 Method for measuring pancreatic metabolism |
| 05/27/2004 | WO2004043497A1 Stabilzation of radiopharmceuticals labeled with 18-f |
| 05/27/2004 | WO2004043492A1 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 05/27/2004 | WO2004043487A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | WO2003033658A3 Neutrokine-alpha and neutrokine-alpha splice variant |
| 05/27/2004 | WO2003019142A9 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 05/27/2004 | WO2003014155A3 Labelled conjugates of p17 protein and their use in aids diagnosis |
| 05/27/2004 | WO2003010175A3 Radiolabeled neuropeptide y y5 receptor antagonists |
| 05/27/2004 | US20040102364 A radioactive cyclized peptide has chemical and metabolic stability, bioavailability, pharmacokinetics; drugs for treating cancers, autoimmune diseases, endocrine disorders, diabetes, gastrointestinal disorders, inflammatory diseases |
| 05/27/2004 | US20040101564 Embolization |
| 05/27/2004 | US20040101527 Complexing monoclonal antibodies with antigens; removal leukocytes; restenosis therapy; antiproliferative agents |
| 05/27/2004 | CA2506091A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | CA2505537A1 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420681A2 Peptide-based multimeric targeted contrast agents |
| 05/26/2004 | EP1149057B1 Biodegradable glass compositions and their use in the manufacture of a medicament for radiation therapy |
| 05/26/2004 | EP0929300B1 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/26/2004 | CN1151377C Method of diagnosing and treating epithelioma |
| 05/25/2004 | US6740305 Feeding patient meal including, as breath test food additive substrate, linear acyl aminoacid peptidomimetic with radioactive or non-radioactively labeled carbon atom, detecting level of labeled carbon dioxide in breath samples |
| 05/25/2004 | US6740304 Receptor binding conjugates |
| 05/21/2004 | WO2004042360A2 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| 05/21/2004 | WO2004041311A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 05/21/2004 | WO2004041302A1 Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator |
| 05/21/2004 | WO2004041296A2 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 05/21/2004 | WO2004041070A2 Mri probes of membrane potential |
| 05/21/2004 | WO2004041067A2 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | WO2004040972A2 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
| 05/21/2004 | CA2507404A1 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
| 05/21/2004 | CA2503561A1 Prevention and treatment of synucleinopathic disease |
| 05/20/2004 | US20040097735 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040096508 A polymeric solution capable of gelling upon exposure to a critical minimum value of a plurality of environmental stimuli is disclosed. The polymeric solution may be an aqueous solution utilized in vivo and capable of having the gelation |
| 05/20/2004 | US20040096394 Conjugating radioiodinated peptides to non-metabolizable carbohydrates |
| 05/20/2004 | US20040096393 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 05/19/2004 | EP1419788A1 Contrast agent for the identification of lymph nodes |
| 05/19/2004 | EP1419786A1 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 05/19/2004 | EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/19/2004 | EP1418950A1 Solid-phase nucleophilic fluorination |
| 05/19/2004 | EP1418808A1 Imaging marker transgenes |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737064 Antitumor agents |
| 05/18/2004 | US6737040 Method and antibody for imaging breast cancer |
| 05/18/2004 | US6737039 Administering luteinizing hormone releasing hormone (lhrh) antagonist in an amount and for a period of time sufficient to reduce breast density in the subject prior to generating an image of breast tissue of the subject |
| 05/18/2004 | US6736769 Radioactivity local delivery system |
| 05/13/2004 | WO2004039842A2 Humanized tissue factor antibodies |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/13/2004 | US20040091421 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 05/12/2004 | EP1417977A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 05/12/2004 | EP1417222A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralzing annti-p17 antibodies which specifically recognize said neutralizing epitope |
| 05/12/2004 | EP1417183A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/12/2004 | EP1416971A1 Gene transfer imaging and uses thereof |
| 05/12/2004 | EP1416963A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 05/12/2004 | EP1244638B1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 05/12/2004 | EP0946510B1 Novel compounds with analgesic effect |
| 05/12/2004 | EP0917464B1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | EP0710261B1 Biodegradable particles |
| 05/11/2004 | US6733743 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 05/06/2004 | WO2004038374A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 05/06/2004 | WO2004037801A1 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 05/06/2004 | WO2004037298A1 Method for determining gastric evacuation using a 13c-labelled test meal |
| 05/06/2004 | WO2004037297A1 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic |
| 05/06/2004 | WO2004037296A2 Method for the production of hyperpolarized 129xe |
| 05/06/2004 | WO2004009135A3 Conjugates of biocompatible polymers with nuclide activation therapy reagents |
| 05/06/2004 | WO2003027148A8 Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging |
| 05/06/2004 | US20040087829 Radioactive seed with multiple markers and method for using same |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087567 Anticancer agents; particularly liver cancer |
| 05/06/2004 | US20040087494 Glycopeptide carboxy-saccharide derivatives |
| 05/06/2004 | US20040086454 In situ radioimmunoassay; immunotherapy; coupling modified peptide to monoclonal antibodies |
| 05/06/2004 | US20040086453 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |